Content related to A First Clinical Trial for Down Syndrome Regression Disorder

An experimental treatment for Down syndrome regression disorder is helping one young teen recover her ability to function in the world.

Jonathan Santoro, MD, shares his team’s latest research and fellowship—and why he’s in a ‘race’ to discover new approaches to care.

Program focuses on early treatment to prevent disability.

Watching 11-year-old Isaiah play hockey, one might think he had the sport in his blood. No. 71 is always the fastest kid on the ice, chasing down the puck with seemingly effortless speed. His has a

“With MIS-C, it’s important to test kids six months after their illness because they can have residual heart inflammation,” says Andrew Souza, DO.

This rare neurological condition requires specialized treatment and may have a link to COVID-19.

Kawasaki disease, sometimes called Kawasaki syndrome, is a serious inflammation of the blood vessels which affects young children, often under 5 years of age.

A clinical trial at Children’s Hospital Los Angeles is the first to study butyrate therapy in Hispanic children with ulcerative colitis.

Since Elise Martinez was 2 years old, she was debilitated by a condition that could not be properly diagnosed. It caused severe impaction in the bowels, arthritis and malnutrition. The many pediatric